Morgan Stanley’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Morgan Stanley’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-375,256	Closed	-$12.5M	–	8257
2024 Q3	$12.5M	Buy	375,256 +296,611	+377%	+$10.2M	﹤0.01%	3250
2024 Q2	$2.13M	Sell	78,645 -4,915	-6%	-$96.9K	﹤0.01%	4528
2024 Q1	$1.8M	Buy	83,560 +19,912	+31%	+$434K	﹤0.01%	4652
2023 Q4	$384K	Buy	63,648 +56,586	+801%	+$282K	﹤0.01%	5719
2023 Q3	$39.3K	Sell	7,062 -3,758	-35%	-$24.2K	﹤0.01%	6266
2023 Q2	$79.4K	Buy	10,820 +10,651	+6,302%	+$80.6K	﹤0.01%	6042
2023 Q1	$678	Buy	169 +166	+5,533%	+$811	﹤0.01%	7399
2022 Q4	$10	Hold	3	–	–	﹤0.01%	7811
2022 Q3	$0	Buy	+3	New	+$11	﹤0.01%	8223
2022 Q2	–	Sell	-5	Closed	–	–	8335
2022 Q1	$0	Buy	5 +4	+400%	+$19	﹤0.01%	8412
2021 Q4	$0	Buy	+1	New	+$7	﹤0.01%	8470

Morgan Stanley's LBPH Position: Q4 2024 in Review

Morgan Stanley sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 375,256 shares — an estimated $12.5M sold.

Morgan Stanley first reported a position in LBPH in Q4 2021 and held it in 11 quarters. The position peaked at $12.5M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Morgan Stanley reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Morgan Stanley sold 375,256 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $12.5M.
Morgan Stanley first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Morgan Stanley's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $12.5M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.